Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS H CAMACHO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1336249960
CMS profile
332515
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$42,307.29

120 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–120 of 120 matching records. This page contains 20 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS H CAMACHO

NPI 1336249960 · CMS profile ID 332515

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–120 of 120 matching records. This page contains 20 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336249960?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS H CAMACHO, NPI 1336249960, CMS profile ID 332515. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–120 of 120 matching records. This page contains 20 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336249960?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LUIS H CAMACHO, NPI 1336249960, CMS profile ID 332515. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–120 of 120 matching records. This page contains 20 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336249960?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LUIS H CAMACHO, NPI 1336249960, CMS profile ID 332515, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–120 of 120 matching records. This page contains 20 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1336249960?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

120 matching records · $42,307.29 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 120 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–120 of 120.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $24.3703/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914928553 CMS
AstraZeneca Pharmaceuticals LP $21.1903/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915236863 CMS
AstraZeneca Pharmaceuticals LP $4.7103/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915309753 CMS
Amgen Inc. $21.6003/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940056465 CMS
Celgene Corporation $22.3003/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932931095 CMS
Celgene Corporation $3.2903/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932931097 CMS
Merck Sharp & Dohme LLC $20.7903/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944144291 CMS
PFIZER INC. $24.2703/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949104669 CMS
Amgen Inc. $26.4702/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940056473 CMS
MorphoSys, US Inc. $25.0002/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962540809 CMS
Incyte Corporation $23.4202/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943018477 CMS
Seagen Inc. $18.3902/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904084539 CMS
Seagen Inc. $55.0002/14/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904084571 CMS
Novartis Pharmaceuticals Corporation $18.6302/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893554589 CMS
PFIZER INC. $27.9102/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949103035 CMS
EISAI INC. $22.5402/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908058659 CMS
AstraZeneca Pharmaceuticals LP $24.0201/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915886489 CMS
Merck Sharp & Dohme LLC $4,270.0001/26/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944031845 CMS
Merck Sharp & Dohme LLC $150.0001/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944031839 CMS
PFIZER INC. $23.1301/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949101529 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $107,763.32 218
PY2020 $33,257.97 66
PY2021 $11,590.93 57
PY2022 $42,307.29 120
PY2023 $31,009.03 95
PY2024 $30,121.11 84
PY2025 $19,605.35 84

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $54,407.85 10
PY2024 Principal investigator $120,222.66 12
PY2023 Principal investigator $21,000.00 1
PY2021 Principal investigator $165,000.00 2
PY2019 Principal investigator $1,820.40 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 TAIHO ONCOLOGY, INC. $8,787.00 06/05/2025 Non-covered Recipient Entity
PCRS NETWORK LLC
Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusions or Rearrangements No dispute reported 06/30/2026 1211418383
Principal investigator 1 TAIHO ONCOLOGY, INC. $2,548.00 05/29/2025 Non-covered Recipient Entity
PCRS NETWORK LLC
Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusions or Rearrangements No dispute reported 06/30/2026 1211419053
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $4,500.00 04/01/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20X ANTI-CD3 BISPECIFIC ANTIBODY, COMBINED WITH CHEMOTHERAPY VERSUS RITUXIMAB COMBINED WITH CHEMOTHERAPY IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-2) No dispute reported 06/30/2026 1184180826
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,350.00 04/01/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20X ANTI-CD3 BISPECIFIC ANTIBODY, COMBINED WITH CHEMOTHERAPY VERSUS RITUXIMAB COMBINED WITH CHEMOTHERAPY IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-2) No dispute reported 06/30/2026 1184180828
Principal investigator 1 TAIHO ONCOLOGY, INC. $2,583.00 03/27/2025 Non-covered Recipient Entity
PCRS NETWORK LLC
Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusions or Rearrangements No dispute reported 06/30/2026 1211415557
Principal investigator 1 Amgen Inc. $14,739.85 02/22/2025 Non-covered Recipient Entity
CENTER FOR ONCOLOGY AND BLOOD DISORDERS
A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors No dispute reported 06/30/2026 1246640165
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $4,500.00 02/18/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1184154216
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,450.00 02/18/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1184154218
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,450.00 01/23/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN LABEL, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH CHOP (O-CHOP) VERSUS RITUXIMAB IN COMBINATION WITH CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PARTICIPANTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (OLYMPIA-3) No dispute reported 06/30/2026 1184149336
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $10,500.00 01/23/2025 Non-covered Recipient Entity
CLINVAX CLINICAL TRIAL SOLUTION LLC
A PHASE 3, OPEN LABEL, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN COMBINATION WITH CHOP (O-CHOP) VERSUS RITUXIMAB IN COMBINATION WITH CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PARTICIPANTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (OLYMPIA-3) No dispute reported 06/30/2026 1184149338